BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 26944412)

  • 1. Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis.
    Pardo A; Cabrera S; Maldonado M; Selman M
    Respir Res; 2016 Mar; 17():23. PubMed ID: 26944412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis.
    Craig VJ; Zhang L; Hagood JS; Owen CA
    Am J Respir Cell Mol Biol; 2015 Nov; 53(5):585-600. PubMed ID: 26121236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Tale of Two Proteolytic Machines: Matrix Metalloproteinases and the Ubiquitin-Proteasome System in Pulmonary Fibrosis.
    Roque W; Boni A; Martinez-Manzano J; Romero F
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis.
    Pardo A; Selman M
    Ann Am Thorac Soc; 2016 Dec; 13 Suppl 5():S417-S421. PubMed ID: 28005427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis.
    Wollin L; Wex E; Pautsch A; Schnapp G; Hostettler KE; Stowasser S; Kolb M
    Eur Respir J; 2015 May; 45(5):1434-45. PubMed ID: 25745043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteases in aberrant fibrotic tissue remodeling.
    Pardo A; Selman M
    Proc Am Thorac Soc; 2006 Jun; 3(4):383-8. PubMed ID: 16738205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained activation of toll-like receptor 9 induces an invasive phenotype in lung fibroblasts: possible implications in idiopathic pulmonary fibrosis.
    Kirillov V; Siler JT; Ramadass M; Ge L; Davis J; Grant G; Nathan SD; Jarai G; Trujillo G
    Am J Pathol; 2015 Apr; 185(4):943-57. PubMed ID: 25660181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.
    Hostettler KE; Zhong J; Papakonstantinou E; Karakiulakis G; Tamm M; Seidel P; Sun Q; Mandal J; Lardinois D; Lambers C; Roth M
    Respir Res; 2014 Dec; 15(1):157. PubMed ID: 25496490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis.
    Tjin G; White ES; Faiz A; Sicard D; Tschumperlin DJ; Mahar A; Kable EPW; Burgess JK
    Dis Model Mech; 2017 Nov; 10(11):1301-1312. PubMed ID: 29125826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of dimethylarginine dimethylaminohydrolase (DDAH) in pulmonary fibrosis.
    Janssen W; Pullamsetti SS; Cooke J; Weissmann N; Guenther A; Schermuly RT
    J Pathol; 2013 Jan; 229(2):242-9. PubMed ID: 23097221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular matrix remodeling in idiopathic pulmonary fibrosis. It is the 'bed' that counts and not 'the sleepers'.
    Tomos IP; Tzouvelekis A; Aidinis V; Manali ED; Bouros E; Bouros D; Papiris SA
    Expert Rev Respir Med; 2017 Apr; 11(4):299-309. PubMed ID: 28274188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic pulmonary fibrosis.
    King TE; Pardo A; Selman M
    Lancet; 2011 Dec; 378(9807):1949-61. PubMed ID: 21719092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metalloproteinases in idiopathic pulmonary fibrosis.
    Dancer RC; Wood AM; Thickett DR
    Eur Respir J; 2011 Dec; 38(6):1461-7. PubMed ID: 21700608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase: An upcoming therapeutic approach for idiopathic pulmonary fibrosis.
    Mahalanobish S; Saha S; Dutta S; Sil PC
    Pharmacol Res; 2020 Feb; 152():104591. PubMed ID: 31837390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast cell chymase: an indispensable instrument in the pathological symphony of idiopathic pulmonary fibrosis?
    Kosanovic D; Dahal BK; Wygrecka M; Reiss I; Günther A; Ghofrani HA; Weissmann N; Grimminger F; Seeger W; Schermuly RT; Banat GA
    Histol Histopathol; 2013 Jun; 28(6):691-9. PubMed ID: 23436625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of matrix metaloproteases in idiopathic pulmonary fibrosis.
    Pardo A; Selman M
    Fibrogenesis Tissue Repair; 2012; 5(Suppl 1):S9. PubMed ID: 23259796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The leading role of epithelial cells in the pathogenesis of idiopathic pulmonary fibrosis.
    Selman M; Pardo A
    Cell Signal; 2020 Feb; 66():109482. PubMed ID: 31760172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase D is increased and activated in lung epithelial cells and macrophages in idiopathic pulmonary fibrosis.
    Gan H; McKenzie R; Hao Q; Idell S; Tang H
    PLoS One; 2014; 9(7):e101983. PubMed ID: 25000413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation and Nuclear Location of MMP28 in Alveolar Epithelium of Idiopathic Pulmonary Fibrosis.
    Maldonado M; Salgado-Aguayo A; Herrera I; Cabrera S; Ortíz-Quintero B; Staab-Weijnitz CA; Eickelberg O; Ramírez R; Manicone AM; Selman M; Pardo A
    Am J Respir Cell Mol Biol; 2018 Jul; 59(1):77-86. PubMed ID: 29373068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMP expression and abnormal lung permeability are important determinants of outcome in IPF.
    McKeown S; Richter AG; O'Kane C; McAuley DF; Thickett DR
    Eur Respir J; 2009 Jan; 33(1):77-84. PubMed ID: 18829682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.